Vimarsana
Biggest News Aggregation in the World

Page 6 - Second Genome News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Second Genome. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Second Genome Today - Breaking & Trending Today

Second Genome to Host Virtual KOL Event to Discuss the Role of Mucosal Healing and PAI-1/2 in Inflammatory Bowel Disease on February 23 - Vimarsana News

Second Genome to Host Virtual KOL Event to Discuss the Role of Mucosal Healing and PAI-1/2 in Inflammatory Bowel Disease on February 23

/PRNewswire/ -- Second Genome, a biotechnology company that leverages its proprietary platform to discover and develop precision therapies and biomarkers,...

Second Genome to Host Virtual KOL Event to Discuss the Role of Mucosal Healing and PAI-1/2 in Inflammatory Bowel Disease on February 23 - Vimarsana News

Second Genome to Host Virtual KOL Event to Discuss the Role of Mucosal Healing and PAI-1/2 in Inflammatory Bowel Disease on February 23

/PRNewswire/ -- Second Genome, a biotechnology company that leverages its proprietary platform to discover and develop precision therapies and biomarkers,...

Second Genome Nominates Development Candidate Targeting PAI-1/2 for the Treatment of Inflammatory Bowel Disease (IBD) - Vimarsana News

Second Genome Nominates Development Candidate Targeting PAI-1/2 for the Treatment of Inflammatory Bowel Disease (IBD)

/PRNewswire/ -- Second Genome, a biotechnology company that leverages its proprietary platform to discover and develop precision therapies and biomarkers,...

Worldwide Genomic Biomarker Industry to 2027 - by Disease Indication, End-user and Region - Vimarsana News

Worldwide Genomic Biomarker Industry to 2027 - by Disease Indication, End-user and Region

/PRNewswire/ -- The "Global Genomic Biomarker Market 2021-2027" report has been added to ResearchAndMarkets.com's offering. The global genomics biomarker...

Second Genome Appoints Joseph Dal Porto, Ph.D., as Chief Scientific Officer - Vimarsana News

Second Genome Appoints Joseph Dal Porto, Ph.D., as Chief Scientific Officer

/PRNewswire/ -- Second Genome, a biotechnology company that leverages its proprietary platform to discover and develop precision therapies and biomarkers from...